Leo Pharma Investigational Site

Fountain Valley, California 92708

1 studies enrolling now · 7 studies all time

What they study most

Atopic Dermatitis, Atopic Hand Eczema, Palmoplantar Pustulosis

Studies at this site

• A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis — Recruiting now
• A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy — Completed
• An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis. — Completed
• Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5) — Completed
• Long-term Extension Trial in Subjects With Atopic Dermatitis Who Participated in Previous Tralokinumab Trials - ECZTEND — Completed
• Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6). — Completed
• Delgocitinib Cream for the Treatment of Moderate to Severe Atopic Dermatitis During 8 Weeks in Adults, Adolescents, and Children — Completed